Market news

British American Tobacco (BAT), a UK-based tobacco and nicotine products company, said that it will set out its plans for the next few years on Tuesday. BAT said it would set out its Horizon 2030 ambitions at its 2026 Capital Markets Day and explain why it believes it is well positioned to deliver sustainable shareholder value in a growing global nicotine industry.

British American Tobacco (BTI) continues to expect 2026 adjusted earnings per share growth towards t

British American Tobacco (LSE:BATS) shares fell 1. 7% on Tuesday after the company said it expects fiscal 2026 revenue and adjusted profit from operations growth to be towards the lower end of its existing guidance ranges.

British American Tobacco (LSE:BATS) has drawn fresh attention after recent performance data showed mixed returns across timeframes, including a small decline over the past day and a gain over the past year for shareholders. At a share price of £41.91, British American Tobacco has seen short term momentum cool after a 1-day share price return that declined 0.76%, even though its 7-day share price return gained 4.00%. Multi year total shareholder returns of 93.02% over three years and 127.04%...

British American Tobacco has delivered a 131.1% return over the past 5 years, which puts a lot of weight on the question of whether its current share price is properly anchored in its earnings power. With the stock recently closing at £42.23, the key issue for investors now is how much of the business's profit engine is already reflected in that figure. A 131.1% gain over 5 years means anyone looking at British American Tobacco today is effectively asking whether earnings can support that...

Nigel Farage has promised to scrap the law that will ban everyone born after 2008 from smoking

Philip Morris, British American Tobacco and Altria have been highlighted in this Industry Outlook article.

British American Tobacco offers compelling value, trading at 11.5x forward earnings with a 6% dividend yield. Click here to read this BTI stock update.

Small but fast-growing segment seen as growth area as it gains greater acceptance from regulators

Tipranks Press Release.

British American Tobacco has delivered a very strong 5 year share price gain, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) still suggest the stock trades at a discount to what its cash flows imply. The share price is up about 126.7% over 5 years, which puts recent short term weakness into context for anyone judging the current entry point. The expanded multi year technology partnership with ITC Infotech can support efficiency and cash...

Why the latest technology agreement matters for British American Tobacco British American Tobacco (LSE:BATS) has been in focus after ITC Infotech Limited announced a multi year technology services agreement covering operations in Poland, Romania and India, along with support for existing hubs in Malaysia and Mexico. See our latest analysis for British American Tobacco. The new technology agreement lands after a weaker spell for British American Tobacco’s share price, which is down 13.36% over...

British American Tobacco (LSE:BATS) has agreed a multi year technology partnership with ITC Infotech covering key markets. The deal includes collaboration on expanding capabilities at BAT's Future Capabilities Centre in India. ITC Infotech is set to provide technology services aimed at streamlining delivery and improving operational efficiency for BAT. This kind of long term digital investment is not unique to British American Tobacco, so it can be worth looking at other under the radar...

BANGALORE, India & LONDON, August 12, 2026--ITC Infotech today announced a landmark multi-year strategic technology deal with British American Tobacco (BAT).

British American Tobacco (LSE:BATS) reported first-half 2026 results that were broadly in line with expectations, with smokeless products accounting for 19. 8% of total group revenue.

New category revenue surged 18% driven by Modern Oral, while EPS guidance was raised to the middle of the 5%-8% range, though APMEA weakness and heated product declines tempered overall performance.